The Journal of Immunology, Vol 155, Issue 5 2679-2687, Copyright © 1995 by American Association of Immunologists

ARTICLES

A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice

EI Buzas, FR Brennan, K Mikecz, M Garzo, G Negroiu, K Hollo, G Cs-Szabo, E Pintye and TT Glant
Department of Biochemistry, Rush Medical University at Rush- Presbyterian St. Luke's Medical Center, Chicago, IL 60612, USA.

Aggrecan, the high buoyant density cartilage proteoglycan (PG), has been shown to induce progressive polyarthritis and ankylosing spondylitis in genetically susceptible BALB/c mice. To further characterize the nature of the autopathogenic effector T cells operating in these mice and to determine the region(s) of the PG molecule recognized by these T cells, we generated PG-specific T cell hybridomas from arthritic mice. One of the PG-specific T cell hybridomas (5/4E8), when injected into naive irradiated BALB/c mice, was capable of inducing clinical and histopathologic signs of arthritis. Massive swelling and redness of the paws dominated the clinical picture. A reactive synovial cell proliferation, the accumulation of hybridoma and inflammatory cells in the enlarged joint space, the loss of PG from the superficial layer of the articular cartilage, and the erosion of articular surface were identical histopathologic signs to those found either in primary or adoptive transfer of PG-induced arthritis. The PG-specific and arthritogenic T cell hybridoma (5/4E8) expressed TCR-alpha beta + (V beta 4), CD4+, and CD8- phenotypes and belonged to the Th1 subset, as the cells secreted IL-2 and IFN-gamma, but not IL-4 upon PG stimulation, and the response was MHC class II (I-Ad)-restricted. These observations provide direct evidence that PG-specific Th cells play crucial roles in autoimmune arthritic processes.

This article has been cited by other articles:

				I. Jelinek, V. Laszlo, E. Buzas, E. Pallinger, B. Hangya, Z. Horvath, and A. Falus Increased antigen presentation and Th1 polarization in genetically histamine-free mice Int. Immunol., January 1, 2007; 19(1): 51 - 58. [Abstract] [Full Text] [PDF]

				J Zou, H Appel, M Rudwaleit, A Thiel, and J Sieper Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis Ann Rheum Dis, May 1, 2005; 64(5): 722 - 729. [Abstract] [Full Text] [PDF]

				E. I. Buzas, A. Hanyecz, Y. Murad, F. Hudecz, E. Rajnavolgyi, K. Mikecz, and T. T. Glant Differential Recognition of Altered Peptide Ligands Distinguishes Two Functionally Discordant (Arthritogenic and Nonarthritogenic) Autoreactive T Cell Hybridoma Clones J. Immunol., September 15, 2003; 171(6): 3025 - 3033. [Abstract] [Full Text] [PDF]

				T. Bardos, K. Mikecz, A. Finnegan, J. Zhang, and T. T. Glant T and B Cell Recovery in Arthritis Adoptively Transferred to SCID Mice: Antigen-Specific Activation Is Required for Restoration of Autopathogenic CD4+ Th1 Cells in a Syngeneic System J. Immunol., June 15, 2002; 168(12): 6013 - 6021. [Abstract] [Full Text] [PDF]

				T. Bardos, R. V. Kamath, K. Mikecz, and T. T. Glant Anti-Inflammatory and Chondroprotective Effect of TSG-6 (Tumor Necrosis Factor-{alpha}-Stimulated Gene-6) in Murine Models of Experimental Arthritis Am. J. Pathol., November 1, 2001; 159(5): 1711 - 1721. [Abstract] [Full Text] [PDF]

				M. Shi, K. Dennis, J. J. Peschon, R. Chandrasekaran, and K. Mikecz Antibody-Induced Shedding of CD44 from Adherent Cells Is Linked to the Assembly of the Cytoskeleton J. Immunol., July 1, 2001; 167(1): 123 - 131. [Abstract] [Full Text] [PDF]

				J. Zhang, T. Bardos, K. Mikecz, A. Finnegan, and T. T. Glant Impaired Fas Signaling Pathway Is Involved in Defective T Cell Apoptosis in Autoimmune Murine Arthritis J. Immunol., April 15, 2001; 166(8): 4981 - 4986. [Abstract] [Full Text] [PDF]

				P. D W KIELY The Th1-Th2 model---what relevance to inflammatory arthritis? Ann Rheum Dis, June 1, 1998; 57(6): 328 - 330. [Full Text]

				T. T. Glant, E. I. Buzas, A. Finnegan, G. Negroiu, G. Cs-Szabo, and K. Mikecz Critical Roles of Glycosaminoglycan Side Chains of Cartilage Proteoglycan (Aggrecan) in Antigen Recognition and Presentation J. Immunol., April 15, 1998; 160(8): 3812 - 3819. [Abstract] [Full Text] [PDF]